The latest price target for ChromaDex (NASDAQ:CDXC) was reported by Roth MKM on November 6, 2024. The analyst firm set a price target for $8.00 expecting CDXC to rise to within 12 months (a possible 45.72% upside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for ChromaDex (NASDAQ:CDXC) was provided by Roth MKM, and ChromaDex maintained their buy rating.

There is no last upgrade for ChromaDex

The last downgrade for ChromaDex Corp happened on August 16, 2022 when Oppenheimer changed their price target from N/A to N/A for ChromaDex Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ChromaDex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ChromaDex was filed on November 6, 2024 so you should expect the next rating to be made available sometime around November 6, 2025.

While ratings are subjective and will change, the latest ChromaDex (CDXC) rating was a maintained with a price target of $6.00 to $8.00. The current price ChromaDex (CDXC) is trading at is $5.49, which is out of the analyst’s predicted range.